Femur vs tibia: which bone gets lengthened first?

Ask a high-volume surgeon at the Paley Institute, HSS, Rubin Institute, Wanna Be Taller or AFA which bone they prefer to lengthen first, and the answer is the same: the femur. The default exists for three converging reasons.

The femur tolerates more length in one stage. Six to eight centimetres is comfortable; eight to ten is achievable in experienced hands with careful patient selection. The tibia caps lower — five to seven centimetres typical, eight only in exceptional cases. The difference is bone geometry and soft-tissue envelope: the femur has more medullary canal volume for an internal nail, more surrounding muscle mass to stretch with the bone, and a more forgiving neurovascular bundle.

The femur recovers faster despite being the larger bone. Counter-intuitive but consistent in published series. The thigh has thicker muscle and fat cover, richer blood supply to the periosteum, and fewer critical neurovascular structures directly adjacent to the distraction site. The tibia, by contrast, has thin anterior soft-tissue cover (which is why a shin bruise hurts more than a thigh bruise), and the anterior tibial artery and the common peroneal nerve sit closer to the cortex.

The proportional change patients want is mostly a thigh change. Lengthening the femur extends the upper leg, which dominates the visual impression in clothed photographs. Lengthening the tibia extends the lower leg. The standard cosmetic patient who wants to add 5–8 cm to their height finds the femur-only result satisfies their goal — which is why many two-stage patients never come back for the tibia.

Surgery happens on day zero. The surgeon performs a controlled osteotomy on the proximal third of the femoral shaft, inserts the lengthening device (PRECICE 2 internal nail, LON internal nail plus external fixator, or pure Ilizarov), and closes. Two days inpatient, then home on crutches.

Distraction begins on day 5–7 — the latency phase allowing soft callus to start forming at the cut ends. The patient extends the bone by approximately 0.75–1 mm per day, split across three or four short sessions to allow tissue to adapt. Distraction lasts 60–80 days for a 6–8 cm gain.

Consolidation runs from the end of distraction through month 9–12 post-op. The new bone column hardens from soft callus to lamellar bone. Partial weight-bearing returns at 6–10 weeks; full weight-bearing without crutches at 4–5 months for internal-nail methods, 6–8 months for hybrid LON, 8–12 months for pure Ilizarov.

Implant removal happens at 12–18 months for internal-nail methods. Short second surgery, day-case in most centres, a missed piece of many patients' original budget. After removal the patient is structurally finished with the femur — they can run, lift, and resume impact sports at their pre-surgery level. From here, the tibia is optional.

The numbers below come from published case series (JBJS, JOSR), pooled cosmetic-LL outcomes from US and European centres, and clinic-reported data from the directory.

A minority of cosmetic patients are tibia-first cases. Two scenarios drive the inversion.

The patient already has a measurable length discrepancy with a longer thigh and a shorter calf. Most adults have minor segmental discrepancies between sides; some have them between the femur and the tibia of the same leg. If imaging shows the patient is proportionally short in the tibia relative to their femur, lengthening the tibia first restores symmetry rather than exaggerating an asymmetry. This is the most common reason for tibia-first.

The patient's aesthetic priority is calf shape, not thigh length. A subset of patients — typically those motivated by photographs of athletes or models with long lower legs — explicitly want the calf-elongation effect that femur lengthening cannot produce. Honest surgeons disclose that this preference comes with a longer overall recovery and higher complication risk per centimetre gained. It is a valid choice, not a wrong one.

Outside cosmetic indications, tibia-first is common for reconstructive cases — particularly congenital tibial bowing (Blount disease, pseudoarthrosis), post-traumatic tibial shortening, or pediatric length-discrepancy correction. These are not the patients this article is for, but the same anatomical reasoning applies.

Three anatomical facts make the tibia a harder bone to lengthen than the femur. First, the anterior tibial cortex sits directly under thin skin and fat — no thick muscle envelope to absorb the soft-tissue stretch, which is why patients describe more sharp pain during tibial distraction. Second, the common peroneal nerve wraps around the fibular head just below the knee — nerve traction injury is the single most-reported tibial complication, occurring in 5–10% of pooled cases. Third, the pin sites in LON and Ilizarov protocols infect more often in the tibia than the femur because the thin skin provides poor barrier function. Pin-site infection in the tibia runs 15–30%, vs 5–15% in the femur in equivalent protocols. None of these facts is a reason to avoid tibia lengthening — they are reasons to expect a different recovery profile and to insist on a high-volume surgeon.

Patients who want both bones lengthened do them in two stages, almost always 12–18 months apart. The interval is not arbitrary — it is set by bone biology. The lengthened femur must reach full consolidation (the new bone column hardened to lamellar bone), the patient must have completed implant removal, and the patient must have returned to a stable functional baseline before the body is asked to repeat the entire distraction-osteogenesis cycle on a different bone.

Shorter intervals (under 12 months) raise refracture risk on the femur side because the patient is loading impact stress before the new bone has fully matured. Longer intervals (over 24 months) are clinically fine — there is no upper bound — but most patients do not want to extend the full LL journey beyond two years.

At 12–18 months between stages, the total cosmetic-LL journey runs about 2–3 years from first surgery to final return to full activity after the second bone. Most patients in published two-stage series end up at 7–8 cm total femur gain plus 5–6 cm total tibia gain — a real-world ceiling of roughly 12–14 cm (5–5.5 inches) for the patient willing to commit to the full journey.

Lengthening both the femur and the tibia in a single surgery is possible. The LON method allows it because the hardware is relatively simple and the cost addition is modest. A handful of high-volume Turkish surgeons — most famously Dr. Yüksel Yurttaş and Dr. Halil Buldu (LiveLifeTaller) — perform combined femur-and-tibia LON for patients who want 10–14 cm in one go.

The trade-off is real, and patients should understand it before booking. Complication risk is additive: if a single bone carries 25–35% all-complication rate in LON, doing both at once approaches 50–60%. Recovery is harder because the patient cannot offload weight onto an unaffected leg during distraction — both legs are healing simultaneously. Total time off feet runs 12–14 weeks for combined surgery, vs 6–8 weeks if the two stages are done separately.

Most surgeons outside Turkey decline to do combined femur-tibia in a single anaesthesia because the risk profile is not justified by the time savings. The clinical consensus, including at the Paley Institute, HSS and Rubin Institute, is to stage the two surgeries 12–18 months apart. The Turkish exception exists because the cost advantage of combining (one anaesthesia, one hospital stay, one travel trip from international patients) is large enough to outweigh the additional risk for a subset of patients.

Three factors drive the should-I-do-both decision. Read them in order.

What is your height target? Patients targeting under 8 cm total gain should stop after the femur. They will reach their target with one bone, one recovery, one cost. Patients targeting 10+ cm total need both bones — the femur cannot reliably give 10 cm in one stage, and the longer gain compromises proportions if delivered through one bone alone.

How old are you? Patients under 30 heal faster and tolerate the second stage better. Patients over 40 should think harder about whether the second stage is worth the extra year of recovery. Patients over 50 face genuinely diminishing returns — bone healing slows, complication rates rise, the second stage delivers less for more risk.

What is your risk tolerance? Doing one bone caps your complication risk at ~25% (cosmetic LL all-cause). Doing both doubles your exposure even when staged correctly. If the idea of a 50% combined complication probability makes you uncomfortable, plan for the femur only and re-evaluate at the 24-month mark whether the second stage still makes sense.

For most cosmetic patients we see, the right answer is femur-first, see how the result actually looks at 18 months, then decide. See our [how-tall-can-you-get guide](/blog/how-much-taller-limb-lengthening) for the realistic single-stage and two-stage ceilings.